Two-stage selection and testing designs for comparative clinical trials
From MaRDI portal
Publication:3780331
DOI10.1093/biomet/75.2.303zbMath0639.62096OpenAlexW2064399851MaRDI QIDQ3780331
Peter F. Thall, Susan S. Ellenberg, Richard M. Simon
Publication date: 1988
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/75.2.303
selectionclinical trialsexpected sample sizetwo-stage procedurecomparison with a controlcut-off parameters
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Statistical ranking and selection procedures (62F07)
Related Items (33)
A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard ⋮ Benefit–Risk Evaluation of Multi-Stage Adaptive Designs ⋮ A curtailed procedure for selecting among treatments with two Bernoulli endpoints ⋮ One-Stage and Two-Stage Designs for Clinical Trials Using an Indifference-Zone Approach ⋮ A two-stage design for comparing binomial treatments with a standard ⋮ SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION ⋮ Unnamed Item ⋮ Curtailment Procedure for Selecting Among Bernoulli Populations ⋮ Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes ⋮ Admissible and minimax estimation of the parameters of the selected normal population in two-stage adaptive designs under reflected normal loss function ⋮ On estimating the mean of the selected normal population in two-stage adaptive designs ⋮ Simple Sequential Boundaries for Treatment Selection in Multi‐Armed Randomized Clinical Trials with a Control ⋮ A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity ⋮ Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin ⋮ Estimation following selection of the largest of two normal means ⋮ On design and inference for two-stage adaptive clinical trials with dependent data ⋮ A two-stage design for comparative clinical trials: the heteroscedastic solution ⋮ A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials ⋮ Discussion on “A Hybrid Selection and Testing Procedure with Curtailment in Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen ⋮ Discussion on “A Hybrid Selection and Testing Procedure with Curtailment” by Elena M. Buzaianu and Pinyuen Chen ⋮ Authors' Responses ⋮ A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance ⋮ On Selecting Among Treatments with Binomial Outcomes ⋮ Seamlessly Expanding a Randomized Phase II Trial to Phase III ⋮ A review of phase 2-3 clinical trial designs ⋮ Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen ⋮ Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen ⋮ Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen ⋮ Product-Type Probability Bounds of Higher Order ⋮ Point estimates and confidence regions for sequential trials involving selection ⋮ Bayesian approach to two-stage phase trial ⋮ A comparison of methods for constructing confidence intervals after phase II/III clinical trials ⋮ Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
This page was built for publication: Two-stage selection and testing designs for comparative clinical trials
